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CASE REPORT
Maximal Points of Head’s Zone in Fixed Drug Eruption
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Young Joon Seo, M.D., Jeung Hoon Lee, M.D.
Department of Dermatology, College of Medicine, Chungnam National University, Daejeon, Korea
The principles determining the primary localization of 
lesions in fixed drug eruption (FDE) are still unknown. 
Studies investigating the predilection areas in FDE have 
indicated drug-related, trauma-related, or inflammation-rela-
ted specific site involvement, as well as visceracutaneous 
reflex-related specific site involvement. The importance of 
viscerocutaneous reflexes for the location of dermatoses was 
first recognized in the 1960s. Head’s zones are viscero-
cutaneous reflex projection fields on the skin that extend 
over certain dermatomes and possess a reflex-associated 
maximal point. Recently, in a Turkish collective of patients, 
three women with the primary location of FDE lesions on the 
maximal points of Head’s zones were presented. We also 
experienced 3 cases with FDE where the lesions were 
located at specific sites (buttocks), the so-called maximal 
points of Head’s zones, which are known to be the most 
active dermatomal areas of an underlying visceral pathology. 
An underlying internal disturbance (ureter stone, pyelo-
nephritis and chronic pelvic inflammatory disease) was 
found in all 3 patients, corresponding to the organ-related 
maximal point of Head’s zones in each case. In conclusion, 
the primary location of FDE lesions on the maximal points of 
Head’s zones revealed relevant organ disorders with 
corresponding projection fields. (Ann Dermatol 23(S3) S383
∼S386, 2011)
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INTRODUCTION
Fixed drug eruption (FDE) is an unusual drug side effect. 
The disease is defined as recurrent lesions that upon repeated 
uptake of a causative drug, always appear at the same skin 
site. The mystery of site preference in FDE is still un-
resolved. There are a few studies investigating drug-related 
site involvement in FDE
1-3, but there are some anecdotal 
reports on trauma related localization or on the role of 
previous inflammation in FDE
4,5. Recently, in a Turkish 
collective of patients, three women with the primary 
location of FDE lesions on the maximal points of Head’s 
zones were presented
6. Their work-up revealed relevant 
organ disorders with the corresponding projection fields. 
Head’s zones are viscera-cutaneous reflex projection fields 
on the skin that extend over certain dermatomes and 
possess a reflex-associated maximal point
7,8. This paper 
describes these 3 cases, and it appears that the primary 
locations of FDE lie within the reflectorially most active 
parts (especially buttocks) of viscero-cutaneous referral 
from a diseased visceral organ (ureter, urinary bladder, 
kidney, adnexes and uterus), the so-called maximal points 
of Head’s zones.
CASE REPORT
Case 1
A 68-year-old man presented with an erythematous 
plaque lesion, 5 cm in diameter, on the skin of the right 
buttock, which had developed over the previous 3 weeks 
(Fig. 1). The patient reported monthly reactivation of the SS Lee, et al
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Fig. 1. Case 1. Thiazide-induced fixed drug eruption on lumbar
2-maximal point. Right ureter stone (corresponding Head’s zones
for ureter: Th9-L3).
Fig. 2. Case 2. Ciprofloxacin-induced fixed drug eruption on 
lumbar 2-maximal point. Right chronic pyelonephritis (corres-
ponding Head’s zones for kidney: Th9-L3).
Fig. 3. Case 3. Doxycycline-induced fixed drug eruption on 
lumbar 2-maximal point. Chronic pelvic inflammatory disease 
(corresponding Head’s zones for uterus and adnexes: Th10-L4).
lesion, with marked redness and bullae, which healed 
spontaneously within 5∼7 days. Histopathological 
examination was consistent with the diagnosis of FDE. He 
had been taking metformin for the last 10 years because of 
diabetes mellitus. In addition, he occasionally took 
thiazide for right side ureter stones during 3 months. 
Upon oral provocation with one-eighth of thiazide, the 
erythematous lesion reactivated with marked redness and 
bullae, confirming the diagnosis of thiazid-induced FDE. 
According to the diagram of maximal points of Head’s 
zones
7,8, the lesion on the right side of the buttocks was 
consistent with the lumbar 2 (L2)-maximal point, the 
known projection point of the right ureter
8,9.
Case 2
A 79-year-old man presented with an oval shaped, 
erythematous plaque of 7 cm in diameter on the right 
buttock area, respectively, following ingestion of a 500 
mg tablet of ciprofloxacin (Fig. 2). This was his second 
episode of development of a patch following ciprofloxacin 
intake during the last 6 months. He was treated with 
methylprednisolone, 24 mg/day p.o., for 7 days. Within 
one week the lesions cleared, leaving residual hyperpig-
mentation. Histologic examination of a skin biopsy from 
the skin lesion showed eosinophilic spongiosis and 
necrotic keratincytes in the basal and upper layers of the 
epidermis. The diagnosis of FDE was made according to 
the histology and the history of 2 site-specific attacks defi-
nitely following ciprofloxaxin intake. The patient reported 
right-side chronic pyelonephritis of 2 years, respectively. 
The location of the lesion on the skin of the patient’s right 
buttock was consistent with the L2-maximal point, the 
known projection point of the right kidney
8,9.
Case 3
A 23 year-old woman presented with a round shaped 
hyperpigmented patch, 12 cm in diameter on the left 
buttock, on exactly the same site as in an episode 3 
months previously (Fig. 3). Histopathological examination 
was consistent with a diagnosis of FDE. Cefotetan and 
doxycycline were the drugs she had taken occasionally 
during the last 5 months because of chronic pelvic 
inflammatory disease. Within 5 days of withdrawal of the 
suspected drugs, the lesion cleared, leaving residual 
hyperpigmentation. Three months later, she was treated 
with doxycyline to control rosacea on her face that led to 
reactivation of the previous lesion. The case was dia-
gnosed as doxycycline-induced FDE. The location of the 
lesion on the right buttock area was consistent with the Maximal Points of Head’s Zone in Fixed Drug Eruption
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Table 1. Clinical features of fixed drug eruption cases
Case Age Sex Causative agent Past medical 
history Underlying disease Skin lesion site
Maximal 
points of 
Head's zones
Projection site via 
the viscero- 
cutaneous reflex
1 68 M Thiazide Diabetes Right ureter stone Right buttock Ureter
 mellitus
2 79 M Ciprofloxacin None Right acute pyelonephritis Right buttock L2 Kidney
3 23 F Doxcycline None Chronic pelvic Left buttock Uterus, adnexes
 inflammatory disease
M: male, F: female.
L2-maximal point, the known projection point of the 
uterus and adnexes
8,9.
DISCUSSION
FDE is a common drug side effect constituting about 5∼
10% of cutaneous drug reactions. The exact patho-
mehanism of FDE is still unclear. According to recent 
studies, FDE is a type of IV immune reaction that shows 
the role of persistent intra-epidermal effector-memory 
CD8+ T-cells in reactivation, and the role of regulatory 
CD4+ T cells, transiently migrating into the epidermis of 
active FDE lesions, in the resolution of FDE
10-12.  
Clinically, FDE is characterized by the sudden appearance 
of one or several round, sharply defined erythematous 
patches and plaque on the skin after drug administration. 
The lesion has a size of several millimeters up to 10 cm. 
Sites of predilection are the palms and soles, the medial 
aspects of the limbs, and abdomen, but also the lips, 
tongue, and in men the glans penis
13. However, little is 
known about why a FDE lesion comes to its primary 
manifestation in a certain part of the skin. Studies investi-
gating the predilection areas have indicated 1) drug 
related, 2) trauma related, or 3) viscerocutaneous reflex 
related specific site involvement in FDE. It is remarkable 
that some drugs cause FDE predominantly at specific sites. 
A highly significant association was found with naproxen 
and isolated FDE on the lips, and with cortimoxazole and 
FDE on the glans penis
3. On the other hand, some authors 
have reported the role of a previous trauma in the site 
preference of FDE
4,5,14. Patients were reported in whom 
FDE lesions initially appeared at exactly the same site as a 
previous trauma, such as Bacillus Calmette- Guérin 
vaccination
4, burn scars, insect bites, and venepuncture
5, 
or at the site of healed herpes zoster, herpes simplex, or 
cellulitis
14,15. Recently, in a Turkish collective of patients, 
three women with primary location of FDE lesions on the 
maximal points of Head’s zone were presented
6. This 
work-up revealed relevant organ disorders with the 
corresponding projection field. The importance of 
viscerocutaneous reflexes for the location of dermatoses 
was first recognized in the 1960s
7,9. Head’s zones are the 
well known projection areas of visceral organs to the skin 
via the viscero-cutaneous reflex route
16,17. The reflec-
torially most active parts within these areas were defined 
by Hansen & Schliack as maximal points of Head’s 
zones
7,8. It was claimed that in the case of a visceral 
pathology, a reflectorially induced optimal alteration in 
the terrain could arise within the corresponding Head’s 
zones and especially on their maximal points; thus 
providing a preferential site for a dermatose to come to its 
primary manifestation. It has been suggested that suitable 
terrain conditions in the form of a slowing down of blood 
flow, increased permeability, and the resulting alterations 
in the metabolism and functions of related skin areas 
would provide a preferential site for a dermatose to come 
to its primary manifestation. The first, and up until now, 
only case of FDE was a patient with an active duodenal 
ulcer who developed FDE in the duodenal reflex zone of 
the thoracic dermatomes Th6-Th10 after intake of a 
pyrazolone derivative
9. In the 3 cases reported here, FDE 
lesions were located on the buttocks consistent with 
Lumbar 1-3-maximal points, designated as projection 
points of the kidney, ureter, urinary bladder, adnexes, and 
uterus to the skin via the viscera-cutaneous reflex route 
(Table 1). We suggest that any patient with solitary FDE 
lesions on the buttocks should visit a hospital, and the 
possibility of visceral organ (ureter, urinary bladder, 
kidney, adnexes and uterus) pathology should be consi-
dered. Although further studies are required to identify the 
mystery of predilection sites in FDE, viscerocutanoues 
reflex-related specific site involvement theory may be 
another optimal model for studying prediction areas in 
skin disease. 
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